Monthly Archives: July 2017

Monday 31st july 2017

Sorry, this entry is only available in French. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. Le Figaro précise qu’une étude danoise publiée dans la revue spécialisée Heart met en avant les vertus du chocolat pour prévenir l’apparition […]

Posted in Synthèse de presse | Comments closed

Friday 28 july

Sorry, this entry is only available in French. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. La Tribune rapporte une toute nouvelle expérience menée par des chercheurs de l’Oregon Health and Science University, aux Etats-Unis, et publiée mercredi […]

Posted in Synthèse de presse | Comments closed

Thursday 27 july

Sorry, this entry is only available in French. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. Alors que le dernier rapport Onusida a apporté des données très encourageantes aussi bien sur l’accès au traitement que sur la baisse […]

Posted in Synthèse de presse | Comments closed

Wednesday 26 july

Sorry, this entry is only available in French. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. Ce mardi 25 juillet, l’Agence française de sécurité du médicament (ANSM) a annoncé la division par trois de la dose maximale de […]

Posted in Synthèse de presse | Comments closed

Microdystrophin restores muscle strength in Duchenne muscular dystrophy

Researchers from Généthon, the AFM-Téléthon laboratory, Inserm (UMR 1089, Nantes) and the University of London (Royal Holloway) demonstrated the efficacy of an innovative gene therapy in the treatment of Duchenne muscular dystrophy. Indeed, after injecting microdystrophin (a “shortened” version of the dystrophin gene) via a drug vector, the researchers managed to restore muscle strength and stabilise the clinical symptoms in dogs naturally affected by Duchenne muscular dystrophy. A first. This work, published today in Nature Communications, has been achieved thanks to donations from the French Téléthon.

Posted in Press releases, Health technologies | Tagged | Comments closed

Tuesday 25 july

Sorry, this entry is only available in French. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. Ce lundi 24 juillet, des chercheurs ont révélé, dans le cadre de la conférence internationale IAS2017 sur le Sida qui se tient […]

Posted in Synthèse de presse | Comments closed

Monday 24 july

Sorry, this entry is only available in French. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. Comme le précise le journal télévisé du 19.45 sur M6, qui a pour l’occasion interrogé Yves Levy, directeur de l’Inserm et du […]

Posted in Synthèse de presse | Comments closed

Friday 21st July 2017

Sorry, this entry is only available in French. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. Dans une entrevue accordée au magazine trimestriel Figaro Santé, Rémy Slama, directeur de recherche Inserm et président du conseil scientifique du Programme national […]

Posted in Synthèse de presse | Comments closed

Gene therapy: first results in children with Sanfilippo B syndrome

On July 13, 2017, the journal Lancet Neurology published the results of a gene therapy trial conducted in four children with Sanfilippo type B syndrome (also known as MPS IIIB). This trial is the achievement of a two-decade partnership with financial support of AFM-Téléthon and the cooperation of the charity “Vaincre les Maladies Lysosomales” (VML). After monitoring of the treated children for 30 months, Dr. Jean-Michel Heard, from the Institut Pasteur and Inserm, and Professors Marc Tardieu and Michel Zérah, from the Paris public hospital administration (AP-HP) and the Paris-Sud and Paris Descartes Universities, conclude that the treatment was well tolerated and associated with neurocognitive benefits for the patients.

Posted in Cell biology, development and evolution, Press releases | Tagged | Comments closed

Wednesday 19th July 2017

Sorry, this entry is only available in French. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language. L’Agence nationale de sécurité sanitaire de l’alimentation (Anses) a rendu public un récent rapport sur le comportement alimentaire des Français. Il s’agit […]

Posted in Synthèse de presse | Comments closed
fermer
fermer
RSS Youtube